Skip to content

Effect of Vibration Massager Therapy on Non-Specific Low Back Pain

Effect of Vibration Massager Therapy on Non-Specific Low Back Pain: A Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06840795
Enrollment
50
Registered
2025-02-21
Start date
2025-03-01
Completion date
2026-02-15
Last updated
2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Brief summary

The main purpose of this study was to examine the effects of vibratory massage therapy on individuals with non-specific low back pain.

Detailed description

This study will be conducted using a randomized controlled design. Volunteers between the ages of 18-65 with non-specific low back pain will be included in the study. Inclusion criteria are that participants do not have structural pathologies and agree to participate in the study voluntarily. Exclusion criteria include spinal deformities and exercise intolerance. Participants will be randomly divided into two groups. Individuals in the first group will receive vibratory massage therapy, while the second group will be evaluated with standard treatment methods as a control. Both groups will receive treatment 3 times a week for 8 weeks. Participants' quality of life, pain levels, range of motion, and muscle activity will be evaluated before and after treatment. Data will be collected using tools such as SF-36, Oswestry Low Back Pain Index, and VAS (Visual Analog Scale).

Interventions

OTHERconventional physiotherapy

Conventional physiotherapy methods will be applied. Pain relief, electrotherapy, hot applications, ultrasound etc.

OTHERState the device (Theragun PRO Plus)

30-40 Hz, 10 min per session, and the treated regions; for CPT, hot pack 20 min + TENS 20 min + ultrasound \~8 min + supervised exercise. Must match the manuscript exactly.

Sponsors

Uskudar University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Having back pain for the last 3 months VAS ≥ 4 * Between 18-65 years of age. * Volunteers for the study. * Not having undergone surgical intervention in the last 6 months

Exclusion criteria

* Structural spinal pathology or deformity. * Recent spinal surgery. * Chronic bone disease. * Neurological or orthopedic disorders that could interfere with the assessments or treatment program. * Use of hypnotic medication. * Psychological or cognitive conditions that could prevent informed participation or completion of the assessments. Inability to cooperate with the study procedures. -The diagnosis of CNLBP and the absence of suspected serious spinal pathology were determined based on: (Medical history ,Clinical examination ,Available medical records)

Design outcomes

Primary

MeasureTime frameDescription
Oswestry Low Back Pain Disability QuestionnaireBaseline and 8 weeksIt was developed to measure the functionality of individuals. The scale determines functional disability for activities such as sitting, walking, personal care, lifting, social life, travel, and sleep. There are 10 questions in this scale. Each question has 6 options. Participants are asked to choose the definition that best describes their situation from these options. A score of 0-5 is assigned for each of the sentences, and the highest possible score is 50 points. It is evaluated as mild between 1 and 10 points, moderate between 11 and 30 points, and severe between 31 and 50 points.

Secondary

MeasureTime frameDescription
Pittsburgh Sleep Quality IndexBaseline and 8 weeksThe scale is a safe and consistent questionnaire that evaluates the amount of sleep, sleep quality, presence and severity of sleep disorders in individuals in the last month. There are seven components in Pittsburg Sleep Quality Index. These components are subjective sleep quality (component 1), sleep latency (component 2), sleep duration (component 3), habitual sleep efficiency (component 4), sleep disturbance (component 5), sleep medication use (component 6) and daytime dysfunction. (component 7). The evaluation score of each item is between 0-3. The total score obtained varies between 0-21. The higher the score, the worse the sleep quality.
Visual Analog ScaleBaseline and 8 weeks1=no pain, 10=worst pain

Countries

Turkey (Türkiye)

Contacts

STUDY_CHAIRAinaz Vahedi

Uskudar University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 10, 2026